Eagle Pharmaceuticals GAAP EPS of -$0.12, revenue of $48.71M
Source: SeekingAlpha
2025-10-16 11:01:59 ET
More on Eagle Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Eagle Pharmaceuticals GAAP EPS of -$0.12, revenue of $48.71M
Eagle Pharmaceuticals Inc.
NASDAQ: EGRX
EGRX Trading
16.67% G/L:
$0.60 Last:
13,724 Volume:
$0.50 Open:
EGRX Latest News
December 24, 2025 12:30:00 pm
HALPER SADEH LLC ENCOURAGES EAGLE PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
December 07, 2025 03:12:00 pm
Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 30, 2025 06:50:00 am
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
EGRX Stock Data
$3,246,743
9,233,736
3.92%
13
371552%
Pharmaceuticals
Healthcare
US
Woodcliff Lake
